Skip to main content

Toxic Syndromes

  • Chapter
  • First Online:
  • 1648 Accesses

Abstract

Toxic shock syndrome (TSS) is an acute, multisystem, toxin-mediated illness, often resulting in multiorgan failure. It represents the most fulminant expression of a spectrum of disease caused by toxin-producing strains of Staphylococcus aureus and Streptococcus pyogenes (group A streptococcus). TSS results from the ability of bacterial toxins to act as superantigens. Most S. aureus and S. pyogenes infections begin on the skin or mucosal surfaces from direct inflammatory or cytotoxic effects of exotoxins. Despite a mortality rate higher than that of meningococcal septicemia, TSS has not achieved the same level of awareness among health-care professionals, who will generally encounter very few recognized cases during their careers. TSS may present anywhere within the health-care system, from occupational health departments to specialist hospital units, and may progress with a rapidity that, once seen, is never forgotten. It is therefore essential that all health-care practitioners have a sound appreciation of the clinical features, diagnosis, pathophysiology, and treatment of TSS.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997;46(RR-10):1.

    Google Scholar 

  2. Working Group on Severe Streptococcal Infection. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA. 1993;269:390–1.

    Article  Google Scholar 

  3. Murray RJ. Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J. 2005;35 Suppl 2:S106–19.

    Article  PubMed  Google Scholar 

  4. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1–7.

    Article  CAS  PubMed  Google Scholar 

  5. Emma L, Andrew JF. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9:281–90.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Hayashida .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Wien

About this chapter

Cite this chapter

Hayashida, K., Fujioka, M., Murakami-Senju, C., Akita, S. (2015). Toxic Syndromes. In: Téot, L., Meaume, S., Akita, S., Ennis, W.J., del Marmol, V. (eds) Skin Necrosis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1241-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-1241-0_15

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-1240-3

  • Online ISBN: 978-3-7091-1241-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics